✦ LIBER ✦

Combining a dipeptidyl peptidase-4 inhibitor, alogliptin, with pioglitazone improves glycaemic control, lipid profiles and β-cell function in db/db mice

✍ Scribed by Y Moritoh; K Takeuchi; T Asakawa; O Kataoka; H Odaka

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The dipeptidyl peptidase-4 inhibitor alo

✍ Yusuke Moritoh; Koji Takeuchi; Tomoko Asakawa; Osamu Kataoka; Hiroyuki Odaka 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 685 KB

Chronic administration of alogliptin, a

✍ Yusuke Moritoh; Koji Takeuchi; Tomoko Asakawa; Osamu Kataoka; Hiroyuki Odaka 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 808 KB

Effect of initial combination therapy wi

✍ K. H. Yoon; G. R. Shockey; R. Teng; G. T. Golm; P. R. Thakkar; A. G. Meehan; D. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Effect of adding sitagliptin, a dipeptid

✍ R. Brazg; L. Xu; C. Dalla Man; C. Cobelli; K. Thomas; P. P. Stein 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB